Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) have been given an average rating of "Moderate Buy" by the fourteen analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a h...